Lexicon Pharmaceuticals Inc (LXRX) — Net Asset Quality Index
Lexicon Pharmaceuticals Inc (LXRX) has a Net Asset Quality Index of 75.5% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $268.82 Million minus total liabilities of $65.96 Million yields net assets of $202.86 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check how resilient are Lexicon Pharmaceuticals Inc's assets to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Lexicon Pharmaceuticals Inc Net Asset Quality Index Over Time (1999–2025)
This chart shows how Lexicon Pharmaceuticals Inc's Net Asset Quality Index has evolved across 27 annual periods from 1999 to 2025. As of March 2026, the index stands at 75.5%, representing net assets of $202.86 Million against total assets of $268.82 Million USD. See Lexicon Pharmaceuticals Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Lexicon Pharmaceuticals Inc (1999–2025)
The table below presents the year-by-year Net Asset Quality Index for Lexicon Pharmaceuticals Inc from 1999 to 2025, covering 27 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see LXRX market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 58.1% | $107.54 Million | $184.99 Million | $77.45 Million | ▲ +9.2 pp |
| 2024 | 48.9% | $145.95 Million | $298.42 Million | $152.47 Million | ▲ +8.3 pp |
| 2023 | 40.6% | $93.11 Million | $229.43 Million | $136.32 Million | ▼ -19.7 pp |
| 2022 | 60.3% | $117.12 Million | $194.30 Million | $77.17 Million | ▼ -22.7 pp |
| 2021 | 83.0% | $113.59 Million | $136.91 Million | $23.31 Million | ▲ +6.2 pp |
| 2020 | 76.7% | $156.37 Million | $203.79 Million | $47.42 Million | ▲ +48.7 pp |
| 2019 | 28.0% | $117.10 Million | $417.71 Million | $300.61 Million | ▲ +37.3 pp |
| 2018 | -9.3% | $-26.41 Million | $284.14 Million | $310.54 Million | ▼ -21.2 pp |
| 2017 | 11.9% | $52.10 Million | $436.54 Million | $384.44 Million | ▼ -21.2 pp |
| 2016 | 33.1% | $157.40 Million | $475.62 Million | $318.22 Million | ▼ -10.6 pp |
| 2015 | 43.7% | $285.85 Million | $654.83 Million | $368.98 Million | ▼ -16.6 pp |
| 2014 | 60.3% | $284.02 Million | $471.38 Million | $187.36 Million | ▼ -1.8 pp |
| 2013 | 62.1% | $170.16 Million | $274.16 Million | $104.00 Million | ▼ -9.7 pp |
| 2012 | 71.7% | $266.68 Million | $371.78 Million | $105.10 Million | ▲ +2.6 pp |
| 2011 | 69.1% | $297.57 Million | $430.51 Million | $132.94 Million | ▲ +1.8 pp |
| 2010 | 67.3% | $247.02 Million | $366.88 Million | $119.86 Million | ▲ +3.9 pp |
| 2009 | 63.4% | $163.50 Million | $257.76 Million | $94.26 Million | ▼ -11.5 pp |
| 2008 | 74.9% | $195.83 Million | $261.51 Million | $65.68 Million | ▼ -2.7 pp |
| 2007 | 77.6% | $286.57 Million | $369.30 Million | $82.72 Million | ▲ +32.7 pp |
| 2006 | 44.9% | $85.50 Million | $190.27 Million | $104.77 Million | ▲ +5.7 pp |
| 2005 | 39.2% | $85.80 Million | $218.71 Million | $132.91 Million | ▼ -18.1 pp |
| 2004 | 57.4% | $121.59 Million | $211.98 Million | $90.39 Million | ▼ -1.1 pp |
| 2003 | 58.5% | $166.22 Million | $284.20 Million | $117.98 Million | ▼ -25.7 pp |
| 2002 | 84.2% | $169.90 Million | $201.77 Million | $31.87 Million | ▼ -6.8 pp |
| 2001 | 91.0% | $218.37 Million | $239.99 Million | $21.62 Million | ▼ -3.1 pp |
| 2000 | 94.1% | $207.63 Million | $220.69 Million | $13.06 Million | ▲ +57.3 pp |
| 1999 | 36.8% | $8.20 Million | $22.30 Million | $14.10 Million | — |